Polymyalgia rheumatica and giant cell arteritis. Scores and indices for diagnosis and follow-up;Pseudopolyarthrite rhizomélique, maladie de Horton. Critères de diagnostic et de suivi

Revue du Rhumatisme Monographies

Volumn 77, Issue 2, 2010, Pages 76-81

  Masson, Charles ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Biopsie art re temporale; Crit res; Criteria; Diagnosis; Diagnostic; cho doppler des art res temporales; Horton's disease; Maladie de Horton; Polymyalgia rheumatica; Pseudopolyarthrite rhizom lique; Temporal arteries ultrasonography; Temporal artery biopsy

Indexed keywords

BLOOD VESSEL BIOPSY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; ECHOCARDIOGRAPHY; FOLLOW UP; GIANT CELL ARTERITIS; MAGNETIC RESONANCE ANGIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RHEUMATIC POLYMYALGIA; SCORING SYSTEM; SHORT SURVEY; TEMPORAL ARTERY;

EID: 77953741668     PISSN: 18786227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.monrhu.2010.01.005     Document Type: Short Survey

References (28)

1. Masson C. La maladie de Horton. Les cas historiques 2004, ALN édition, Nancy.
2. Masson C. Pseudo-polyarthrite rhumatoide. Maladie de Horton. Encycl Méd Chir (Elsevier, Paris), Appareil Locomoteur, 14-243-A-10, 1997, 13p.
3. Soubrier M., Dubost J.J., Ristori J.M. Polymyalgia rheumatica: diagnosis and treatment. Joint Bone Spine 2006, 73:599-605.
4. Nuenninghoff D.M., Hunder G.G., Christianson T.J.H., et al. Incidence and predictors of large-artery complication (aortic aneuvrysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis. A population-based study over 50 years. Arthritis Rheum 2003, 48:3522-3531.
5. Cantini F., Salvarini C., Olivieri I., et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 2001, 28:1049-1055.
6. McGonagle D., Pease C., Marzo-Ortega H., et al. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. J Rheumatol 2001, 28:1837-1841.
7. Bird H.A., Leeb B.F., Montecucco C.M., et al. A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 2005, 64:626-629.
8. Hunder G.G., Bloch D.A., Michel B.A., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
9. Devauchelle-Pensec V., Jousse S., Destombe C., et al. Epidemiology, imaging, and treatment of giant cell arteritis. Joint Bone Spine 2008, 75:267-272.
10. Schmidt W.A., Kraft H.E., Vorpahl K., et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
11. Schmidt W.A., Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology 2002, 41:46-52.
12. Salvarini C., Silingardi M., Ghirarduzzi A., et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 2002, 137:232-238.
13. Burke A.P., Tavora F., Narula N., et al. Aortitis and ascending aortic aneuvrysm: description of 52 cases and proposal of a histological classification. Human Pathol 2008, 39:514-526.
14. Geiger J., Ness T., Uhl M., et al. Involvement of the ophtalmic artery in giant cell arteritis visualized by 3T MRI. Rheumatology 2009, 48:537-541.
15. Moosig F., Czech N., Mehl C., et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 2004, 63:870-873.
16. Dasgupta B., Salvarini C., Schirmer M., et al. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol 2008, 35:270-277.
17. Bird H.A. Criteria for polymyalgia rheumatica. Tale without end. J Rheumatol 2008, 35:188-189.
18. Marzo-Ortega H., Rhodes L.A., Lyn Tan A., et al. Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis. Arthritis Rheum 2007, 56:3496-3501.
19. Bird H.A., Esselincks W., Dixon A.S.T.J., et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979, 38:434-439.
20. Healey L., Wilske K.R. The systemic manifestations of temporal arteritis 1978, Ed Grune and Stratton, New York, pp. 140.
21. Jones J.G., Hazleman Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981, 40:1-5.
22. Salvarini C, Gabriel SE, O'Fallon WM, et al. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
23. Proven A., Gabriel S.E., O'Fallon W.M., et al. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol 1999, 26:1333-1337.
24. Leeb B.F., Bird H.A., Nesher G., et al. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the Eupean Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT). Ann Rheum Dis 2003, 62:1189-1194.
25. Leeb B.F., Bird H.A. A disease activity score for polymyalgia rheumatica. Ann Rheum Dis 2004, 63:1279-1283.
26. Binard A., de Bandt M., Berthelot J.M., et al. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios. Arthritis Rheum (Arthritis Care Res) 2007, 57:481-486.
27. Binard A., Lefebvre B., De Bandt M., et al. Validity of the polymyalgia rheumatica activity score in primary care practice. Ann Rheum Dis 2009, 68:541-545.
28. Binard A., De Bandt M., Berthelot J.M., et al. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares. Arthritis Rheum 2008, 59:263-269.